Company intelligence / Profile preview

Advanced Separation Technologies

Whippany, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Advanced Separation Technologies, Inc. (Astec) was a premier provider of chiral chromatography products and services, essential for the pharmaceutical, food, and cosmetic industries. Established in 1983, the company pioneered the development of unique bonded phases for the separation of enantiomers, including the widely recognized CHIROBIOTIC, CYCLOBOND, and CHIRALDEX product lines. These technologies enabled researchers to resolve complex racemic mixtures into pure enantiomers, a critical step in drug discovery, development, and quality control. Astec was acquired by Sigma-Aldrich in 2006, and its portfolio continues to be a core component of the MilliporeSigma analytical separation business under Merck KGaA.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on Advanced Separation Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Separation Technologies.

Explore the full profile